<?xml version="1.0" encoding="UTF-8"?>
<ref id="B47-pathogens-09-00331">
 <label>47.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fan</surname>
    <given-names>H.-H.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>L.-Q.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>W.-L.</given-names>
   </name>
   <name>
    <surname>An</surname>
    <given-names>X.-P.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>Z.-D.</given-names>
   </name>
   <name>
    <surname>He</surname>
    <given-names>X.-Q.</given-names>
   </name>
   <name>
    <surname>Song</surname>
    <given-names>L.-H.</given-names>
   </name>
   <name>
    <surname>Tong</surname>
    <given-names>Y.-G.</given-names>
   </name>
  </person-group>
  <article-title>Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus (2019-nCoV) related coronavirus model</article-title>
  <source>Chin. Med. J.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1097/CM9.0000000000000797</pub-id>
 </element-citation>
</ref>
